Osteoporosis drug shows potential against diseases caused by excess iron

Researchers at the University of São Paulo (USP) in Brazil have discovered that two osteoporosis drugs (etidronate and tiludronate) may combat diseases caused by iron accumulation in the body. In tests conducted on human cells, the drugs bound to excess iron, reduced oxidative stress, and prevented cell damage. The study is published in the journal BioMetals.